Meloxidyl (Meloxicam) Oral Suspension, 1.5 mg/mL, 100 mL,1 ct.

Dogs diagnosed with osteoarthritis (OA) or other inflammatory joint conditions may be prescribed Meloxidyl (Meloxicam) Oral Suspension for Dogs. Meloxidyl is an NSAID that works to alleviate joint pain and inflammation, resulting in better mobility and improved quality of life. Meloxidyl comes in a liquid form. FDA approved.How it Works

Meloxicam works by reducing hormones that cause pain and inflammation in the body.

Special Precautions

Keep away from children and animals. The safe use of Meloxidyl (Meloxicam) Oral Suspension in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating dogs has not been evaluated. Meloxicam is not recommended for use in dogs with bleeding disorders, as safety has not been established in dogs with these disorders. As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, renal and hepatic toxicity. Sensitivity to drug-associated adverse events varies with the individual patient. Dogs that have experienced adverse reactions from one NSAID may experience adverse reactions from another NSAID. Patients at greatest risk for renal toxicity are those that are dehydrated, on concomitant diuretic therapy, or those with existing renal, cardiovascular, and/or hepatic dysfunction. Concurrent administration of potentially nephrotoxic drugs should be carefully approached. NSAIDs may inhibit the prostaglandins that maintain normal homeostatic function. Such anti-prostaglandin effects may result in clinically significant disease in patients with underlying or pre-existing disease that has not been previously diagnosed. Since NSAIDs possess the potential to induce gastrointestinal ulcerations and/or perforations, concomitant use with other anti-inflammatory drugs, such as NSAIDs or corticosteroids, should be avoided. If additional pain medication is needed after administration of the total daily dose of Meloxidyl (Meloxicam) Oral Suspension, a non-NSAID or non-corticosteroid class of analgesia should be considered. The use of another NSAID is not recommended. Consider appropriate washout times when switching from corticosteroid use or from one NSAID to another in dogs. The use of concomitantly protein-bound drugs with Meloxidyl (Meloxicam) Oral Suspension has not been studied in dogs. Commonly used protein-bound drugs include cardiac, anticonvulsant and behavioral medications. The influence of concomitant drugs that may inhibit metabolism of Meloxidyl (Meloxicam) Oral Suspension has not been evaluated. Drug compatibility should be monitored in patients requiring adjunctive therapy. For oral use in dogs only. As with any NSAID all dogs should undergo a thorough history and physical examination before the initiation of NSAID therapy. Appropriate laboratory testing to establish hematological and serum biochemical baseline data is recommended prior to and periodically during administration. Owner should be advised to observe their dog for signs of potential drug toxicity and be given a client information sheet about Meloxidyl. See product insert or packaging for full safety information.

Overdose Information

Contact your nearest emergency animal hospital.

Side Effects

GI abnormalities were the most common adverse reactions associated with the administration of meloxicam.

Storage

Store at controlled room temperature 68-77°F (20-25°C).